Clariane SE (FRA:KO2) Dividend-Payout-to-FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:KO2 Clariane SE FRA:KO2
58 GF Score
Price €3.81
GF Value €2.47
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Clariane SE Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.

FRA:KO2
58GF Score
Clariane SE FRA:KO2
Dividend-Payout-to-FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clariane SE (FRA:KO2) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €3.81 is trading 54.3% above its estimated GF Value™ of €2.47. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for FRA:KO2:

  • Dividend-Payout-to-FFO:
  • GF Value™: €2.47 vs. price of €3.81 (54.3% above fair value)
  • GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the FRA:KO2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a European operator of non-acute care services, focused on long-term care and specialist care. Its long-term care activities include medicalized nursing homes for vulnerable older people and alternative living solutions such as assisted-living and home-care services. Its specialist care segment covers post-acute and rehabilitation care, mental health services, and medical, surgical and obstetrics clinics. The company operates through segments spanning France, Germany, Belgium, the Netherlands, Italy and Spain, with France representing its largest market. It serves older adults, patients requiring rehabilitation or psychiatric care, and residents needing supported living, with revenue generated primarily from accommodation fees, care services and reimbursements from public health systems and insurers, alongside private-pay arrangements. Clariane was formerly known as Korian before rebranding.
58GF Score

Get the complete analysis for FRA:KO2

Dividend-Payout-to-FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.81
Price
€2.47
GF Value